Skip to content

Psilocybin (Usona Institute)

DRUG11 trials

Sponsors

University of Washington, Oregon Health and Science University, Johns Hopkins University, James J. Peters Veterans Affairs Medical Center, Trent Emerick

Conditions

AgingAnhedoniaBiomarkers of AgingBurnout, CaregiverBurnout, ProfessionalCOVID-19Chronic Pelvic PainChronic Stroke

Early Phase 1

Phase 1

Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study
Not yet recruitingNCT06988319
Oregon Health and Science UniversityChronic Pelvic Pain
Start: 2026-10-01End: 2027-12-31Target: 15Updated: 2026-08-03
Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability
RecruitingNCT07053917
Johns Hopkins UniversityStroke, Chronic Stroke, Intracerebral Haemorrhage +9
Start: 2026-02-09End: 2027-03-01Target: 20Updated: 2026-02-13
Psilocybin to Treat Depression in Spinal Cord Injury
RecruitingNCT07251491
James J. Peters Veterans Affairs Medical CenterSpinal Cord Injury, Depression - Major Depressive Disorder, Veteran
Start: 2026-08-06End: 2028-03-01Target: 30Updated: 2026-08-10
Psilocybin After Trauma Surgery for Pain
Not yet recruitingNCT07406828
Trent EmerickPain Management, Postoperative Pain
Start: 2027-12-31End: 2029-08-01Target: 70Updated: 2026-08-06
Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects
RecruitingNCT07490353
Medical University of ViennaDepression - Major Depressive Disorder, Anhedonia
Start: 2025-11-01End: 2028-05-31Target: 85Updated: 2026-03-24
Safety and Tolerability Trial of Psilocybin in Healthy Older Adults
RecruitingNCT07516405
University of Colorado, DenverHealthy Volunteer, Older Adults (65-85 Years)
Start: 2026-04-01End: 2028-03-01Target: 40Updated: 2026-08-10
Psilocybin Effects on Healthy Aging Biomarkers and Purpose in Life
Not yet recruitingNCT07719088
Charles RaisonAging, Longevity, Biomarkers of Aging
Start: 2026-12-01End: 2028-12-01Target: 50Updated: 2026-08-17

Phase 2

Phase 3

Related Papers